AI and skin biomarkers: profile of Anastasia Georgievskaya

AI and skin biomarkers: profile of Anastasia Georgievskaya

Anastasia Georgievskaya is using AI to develop biomarkers from photos of consumers’ skin. She is doing important work for the longevity revolution, but the consumers are more attracted by offers of improved attractiveness than offers of extended lifespan. Skin biomarkers Anastasia Georgievskaya runs a company in Estonia that provides consumers with recommendations engines for healthcare and lifestyle changes, using indicators from photographs of their skin. The company is called Haut.AI, and it operates a software platform which solicits images, and also lifestyle and preference data from individuals. It processes this information, and provides the results to clients. The clients include...
Biotech firm puts R2D2 to work in lab

Biotech firm puts R2D2 to work in lab

Applying AI to drug development Drug development is a time-consuming and expensive business. Notoriously, it takes over 10 years and costs around $2 billion to bring one drug to market — and around 90% of candidate drugs fail during human trials. And the situation is getting worse. Eroom’s Law (Moore’s Law in reverse) is the observation that the cost of developing a new drug doubles roughly every nine years. The most promising solution to this problem is applying artificial intelligence to the process. A number of companies are pursuing this, and one of the leaders is Insilico Medicine, which announced...